INDUSTRY × Observational × Uterine Cervical Neoplasms × Clear all ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
Recruiting
105 enrolled
DP-04
Recruiting
100 enrolled
CAMPERR
Recruiting
7,000 enrolled
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
Active not recruiting
1,150 enrolled
HERGYN
Completed
509 enrolled
TraveraRTGx
Recruiting
200 enrolled
RETRACE
Recruiting
200 enrolled
BARHYSTER
Recruiting
132 enrolled
Tempus Priority Study: A Pan-tumor Observational Study
Active not recruiting
1,000 enrolled
A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer
Withdrawn
INSPIRE
Recruiting
5,350 enrolled
GynRNA
Recruiting
2,500 enrolled
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Withdrawn
Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)
Active not recruiting
4,453 enrolled
Safety of Effivia®, a Bevacizumab Biosimilar
Completed
83 enrolled
RADIANT
Completed
16 enrolled
The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer
Not yet recruiting
80 enrolled
GK-01
Recruiting
10 enrolled
Clinical Correlation Between Self-collected and Physician-collected HPV Screening Kits
Completed
344 enrolled
Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine
Recruiting
600 enrolled
Post Market Clinical Follow-up Study Venezia
Completed
41 enrolled
VALTRIHP
Unknown
23,941 enrolled
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
Unknown
3,000 enrolled
EU-VALHUDES
Completed
600 enrolled
HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib
Terminated
1,583 enrolled
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
Completed
6,730 enrolled
PIONEER
Unknown
1,000 enrolled
IMPROVE-COLPO
Completed
7,555 enrolled
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
Completed
321 enrolled
A Study to Evaluate Safety and Effectiveness of Bevacizumab in Combination With Paclitaxel and Cisplatin/Carboplatin or Toptecan in Participants With Advanced Cervical Cancer
Completed
84 enrolled
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
Completed
15 enrolled
European Clinical Evaluation of the BD HPV Assay on the BD Viper LT System
Completed
1,365 enrolled
Type Distribution of Human Papillomavirus in Adult African Women Diagnosed With Invasive Cervical Cancer
Completed
591 enrolled
Study on the Prevalence of Human Papillomavirus Types in Women >= 15 Years of Age in the Kingdom of Saudi Arabia
Completed
420 enrolled
Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System
Completed
2,200 enrolled
Human Papillomavirus (HPV) Type Distribution in Adult Women Diagnosed With Invasive Cervical Cancer in New Zealand
Completed
244 enrolled
Cross-sectional Study on Human Papillomavirus Type Distribution in Adult Women Diagnosed With Cervical Cancer
Completed
40 enrolled
oncoFISH Cervical Test for Detection of 3q26 Region Gain
Unknown
1,100 enrolled
Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer
Unknown
60 enrolled
Imaging the Uterine Cervix - UltraSightHD™
Completed
12 enrolled
Investigation of the Uterine Cervix Using CervicalMD
Completed
26 enrolled